Misinformation and Its Impact on COVID-19 Vaccine Distribution
Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how communicating the safety and efficacy of COVID-19 vaccines to the public is an essential piece of the rollout.
Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how communicating the safety and efficacy of coronavirus disease 2019 (COVID-19) vaccines to the public is an essential piece of the rollout.
For the full conversation, see the video above.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
September 19th 2025
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
September 18th 2025